MAP in Sepsis & Septic Shock

Why sepsis care revolves around MAP

Septic shock is a perfusion problem. The vasculature dilates, SVR collapses, and organs stop getting enough blood — regardless of what the heart is doing. Systolic BP misses this completely. You can have a systolic of 95 and a MAP of 62 and be in serious trouble. Or a systolic of 88 and a MAP of 71 and be doing fine. Systolic tells you the peak ejection pressure. MAP tells you the sustained driving force that actually feeds the organs.

That's why the Surviving Sepsis Campaign targets MAP, not systolic. Every vasopressor titration, every fluid reassessment, every decision in a septic ICU patient orbits a single number.

Where the 65 mmHg number comes from

It's not arbitrary. Around MAP 65 mmHg, the kidney's autoregulatory capacity runs out. Healthy kidneys maintain constant GFR across a MAP range of roughly 70–180 mmHg by adjusting afferent arteriole tone. Below about 65, that mechanism is exhausted and GFR starts falling in a straight line with MAP. Ten mmHg below the threshold produces measurable AKI risk. That's why the number matters.

The gut mucosa starts showing ischaemic changes around the same threshold — bacterial translocation increases, and splanchnic hypoperfusion feeds multi-organ dysfunction. The liver, already underperfused in shock, gets worse. The brain holds out a bit longer under normal conditions (autoregulation down to ~60 mmHg CPP), but that margin disappears in TBI or chronic hypertension.

Sepsis-associated AKI hits up to 50% of ICU patients and is independently tied to 30-day mortality, prolonged ventilation, and long-term CKD. Getting MAP above 65 mmHg is one of the most concrete and immediate things you can do to reduce that risk.

SEPSISPAM — what we learned from pushing MAP higher

The SEPSISPAM trial (Asfar et al., NEJM 2014) was the first serious RCT to ask whether targeting a higher MAP in septic shock actually helps. 776 patients, two groups: MAP 65–70 or MAP 80–85. The answer, broadly, was no — and the higher target caused more atrial fibrillation.

The exception that matters: patients with pre-existing chronic hypertension. In that subgroup, targeting 80–85 mmHg cut RRT requirement from 52% to 39%. That finding makes biological sense — their autoregulation curve has shifted right over years of high-pressure exposure. What's "normal" perfusion pressure for them isn't 65 mmHg.

Fluids first — then vasopressors

The SSC 1-hour bundle says: if MAP is below 65 mmHg or lactate is ≥ 4 mmol/L, start 30 mL/kg IV crystalloid. The idea is to restore preload and cardiac output before reaching for vasopressors. That logic holds.

But 30 mL/kg is a starting point, not a prescription. Fluid in a leaky, inflamed vasculature goes where you don't want it — pulmonary oedema, gut oedema, abdominal compartment syndrome. Once you've given the initial bolus, the question is whether more fluid will actually improve cardiac output. That's where dynamic assessments — pulse pressure variation, stroke volume variation, passive leg raise — earn their keep. If the patient isn't fluid-responsive, stop giving fluid and start the vasopressor.

Vasopressor hierarchy

When fluids aren't enough, vasopressors are how you restore MAP. The SSC 2021 guidelines are clear on the order.

Norepinephrine — start here

Norepinephrine is the most-studied vasopressor in septic shock and the only one with consistent mortality advantage over dopamine in large RCTs. It works primarily through α1 agonism — vasoconstriction, higher SVR, higher MAP — without meaningful tachycardia at normal doses. Start at 0.05–0.1 mcg/kg/min. Titrate in 0.01–0.02 mcg/kg/min steps every 5–15 minutes. There's no hard maximum, but once you're above 0.25–0.5 mcg/kg/min, add a second agent rather than pushing NE further.

Vasopressin — add it, don't escalate instead

When norepinephrine hits 0.25 mcg/kg/min, add vasopressin at 0.03 units/min (fixed, not weight-based, not titrated). Its job is to let you reduce the norepinephrine dose — typically by 20–40% — rather than to independently drive MAP higher. The VASST trial showed it was safe and non-inferior to NE alone, with a possible mortality signal in less severe shock. The mechanism is completely separate from adrenergic pathways: V1 receptors on vascular smooth muscle, direct vasoconstriction. That independence is useful when prolonged septic shock has downregulated the adrenergic system.

Hydrocortisone — for refractory shock

If MAP stays below target on adequate NE plus vasopressin, consider relative adrenal insufficiency. IV hydrocortisone 200 mg/day (continuous or 50 mg q6h) restores vasopressor sensitivity. The ADRENAL trial showed it accelerated shock reversal and reduced ICU duration — no mortality benefit, but faster recovery from the vasopressor-dependent state is clinically meaningful.

Monitoring MAP — arterial line vs NIBP

In the ICU, MAP comes from an arterial line — usually radial artery — giving real-time beat-to-beat readings. That continuous readout is what allows responsive vasopressor titration. The waveform also gives you pulse pressure variation (PPV): in mechanically ventilated patients, PPV above 12–13% means the patient is on the steep part of the Frank-Starling curve and will likely respond to fluid. Below 12%, more fluid won't help cardiac output.

Without arterial access, automated NIBP at 1–5 minute intervals is adequate for most ward-level situations. One caveat: at very low MAPs, NIBP tends to underestimate the true value. That's part of why arterial lines are standard in shock.

Individualising MAP targets

The 65 mmHg SSC target is a population-level floor, not a one-size number. Some patients need more. Getting this wrong in either direction causes harm.

Weaning vasopressors

Once the source is controlled and the patient is clearly recovering, get off vasopressors systematically. Prolonged catecholamine exposure is not benign — it impairs immune function, can cause catecholamine cardiomyopathy, and increases ischaemia risk to extremities.

Signs the patient is ready: MAP holding above target on current or lower doses, lactate falling (clearance ≥ 10–20% per 2 hours), urine output back above 0.5 mL/kg/h, improving responsiveness, warm peripheries. Wean vasopressin before norepinephrine. Reduce NE in 0.02–0.05 mcg/kg/min steps with a MAP check after each one. Don't stop abruptly — the vascular smooth muscle that's been tonically contracted can't immediately take over, and you'll see rebound hypotension.

Key takeaways

• MAP ≥ 65 mmHg is the SSC initial target — it's where renal and splanchnic autoregulation fails in most adults
• SEPSISPAM showed higher MAP targets didn't improve overall mortality and increased AF — except in hypertensive patients, where RRT was reduced
• Start with 30 mL/kg crystalloid, then reassess fluid responsiveness before giving more
• Norepinephrine is first-line; vasopressin at 0.03 units/min fixed dose is added when NE reaches 0.25 mcg/kg/min
• Patients with chronic hypertension, TBI, CAD, or CKD need higher MAP targets — the 65 mmHg floor is not universal
• Arterial line gives continuous MAP plus PPV for fluid responsiveness — standard in septic shock
• Lactate clearance is a co-target. Adequate MAP with persistent high lactate means a different problem
• Wean vasopressors in reverse order, gradually, once source control and recovery are established

Sources & references

• Surviving Sepsis Campaign Guidelines 2021
• Asfar P et al. High versus Low Blood-Pressure Target in Patients with Septic Shock. N Engl J Med 2014 (SEPSISPAM)
• Russell JA et al. Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock. N Engl J Med 2008 (VASST)
• Venkatesh B et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med 2018 (ADRENAL)
• De Backer D et al. Comparison of Dopamine and Norepinephrine in the Treatment of Shock. N Engl J Med 2010
• StatPearls — Mean Arterial Pressure